What are the psychological effects of using synthetic cannabinoids? A systematic review

被引:30
作者
Akram, Hina [1 ,2 ]
Mokrysz, Claire [2 ]
Curran, H. Valerie [2 ]
机构
[1] UCL, Dept Clin Educ & Hlth Psychol, 1-19 Torrington Pl, London WC1E 6BT, England
[2] UCL, UCL Clin Psychopharmacol Unit, London WC1E 6BT, England
基金
英国医学研究理事会;
关键词
Synthetic cannabis; psychological; behavioural; affective; cognitive; depression; anxiety; systematic review; CONSUMPTION; PSYCHOSIS; SPICE; PREVALENCE; ADOLESCENT; TOXICITY; PATTERNS; JWH-018;
D O I
10.1177/0269881119826592
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Synthetic cannabinoids are, typically, full agonists at the cannabinoid CB1 receptor, and therefore considerably more potent than natural cannabis and may have correspondingly more serious psychological effects. Despite government sanctions against their production they continue to be available in ever-increasing varieties over the Internet. The psychological consequences of synthetic cannabinoid use are relatively unknown. Aim: The purpose of this study was to synthesise the available research on the psychological consequences of synthetic cannabinoid use. Method: A literature search of three databases was conducted in February 2018, including the following keywords: Spice, synthetic cannabis, cognition, affect, behaviour, psychosis, depression and anxiety. Results: Seventeen studies involving a variety of participants were eligible for inclusion: one controlled administration study, seven cross-sectional studies, five Internet surveys and four qualitative studies. The controlled administration study showed that, compared to placebo, synthetic cannabinoids acutely affected some aspects of cognitive functioning and subjective psychological ratings. Non-controlled, cross-sectional studies generally showed that synthetic cannabinoid users had lower performance on cognitive tasks and showed elevated symptomatology (e.g. paranoia) compared to both natural cannabis and non-cannabis users. Methodological limitations were noted across different study designs. There is limited research on how doses, frequency or type of synthetic cannabinoid influence outcomes. Conclusions: Acute synthetic cannabinoid use can result in a range of psychological outcomes and, when non-intoxicated, synthetic cannabinoid users appear to differ from natural cannabis and non-users on various affective and cognitive domains. As synthetic cannabinoid use is increasing in at-risk populations there is an urgent need for more and better research to inform users, professionals and policymakers.
引用
收藏
页码:271 / 283
页数:13
相关论文
共 56 条
  • [21] Synthetic cannabinoid JWH-018 and psychosis: An explorative study
    Every-Palmer, Susanna
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2011, 117 (2-3) : 152 - 157
  • [22] Synthetic Cannabinoid Exposures Reported to Texas Poison Centers
    Forrester, Mathias B.
    Kleinschmidt, Kurt
    Schwarz, Evan
    Young, Amy
    [J]. JOURNAL OF ADDICTIVE DISEASES, 2011, 30 (04) : 351 - 358
  • [23] A systematic review of the effects of novel psychoactive substances "legal highs' on people with severe mental illness
    Gray, R.
    Bressington, D.
    Hughes, E.
    Ivanecka, A.
    [J]. JOURNAL OF PSYCHIATRIC AND MENTAL HEALTH NURSING, 2016, 23 (05) : 267 - 281
  • [24] A Survey of Synthetic Cannabinoid Consumption by Current Cannabis Users
    Gunderson, Erik W.
    Haughey, Heather M.
    Ait-Daoud, Nassima
    Joshi, Amruta S.
    Hart, Carl L.
    [J]. SUBSTANCE ABUSE, 2014, 35 (02) : 184 - 189
  • [25] Hermanns-Clausen M, 2017, CLIN TOXICOL, V56, P1
  • [26] Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings
    Hermanns-Clausen, Maren
    Kneisel, Stefan
    Szabo, Bela
    Auwaerter, Volker
    [J]. ADDICTION, 2013, 108 (03) : 534 - 544
  • [27] A Characterization of Synthetic Cannabinoid Exposures Reported to the National Poison Data System in 2010
    Hoyte, Christopher O.
    Jacob, Jeena
    Monte, Andrew A.
    Al-Jumaan, Mohammed
    Bronstein, Alvin C.
    Heard, Kennon J.
    [J]. ANNALS OF EMERGENCY MEDICINE, 2012, 60 (04) : 435 - 438
  • [28] The Synthetic Cannabinoids Phenomenon
    Karila, Laurent
    Benyamina, Amine
    Blecha, Lisa
    Cottencin, Olivier
    Billieux, Joel
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (42) : 6420 - 6425
  • [29] Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis
    Kassai, Szilvia
    Pinter, Judit Nora
    Racz, Jozsef
    Borondi, Brigitta
    Toth-Kariko, Tamas
    Kerekes, Kitti
    Gyarmathy, V. Anna
    [J]. HARM REDUCTION JOURNAL, 2017, 14
  • [30] Electroconvulsive Therapy (ECT) for Catatonia in a Patient With Schizophrenia and Synthetic Cannabinoid Abuse A Case Report
    Leibu, Evan
    Garakani, Amir
    McGonigle, Daniel P.
    Liebman, Lauren S.
    Loh, Daniella
    Bryson, Ethan O.
    Kellner, Charles H.
    [J]. JOURNAL OF ECT, 2013, 29 (04) : E61 - E62